[1]
B. Önal, “Tocilizumab Treatment Affects Intensive Care Unit Admission Rates of COVID-19 Patients in a Dose-dependent Manner”, Cerrahpaşa Medical Journal, vol. 45, no. 3, pp. 177–184, Sep. 2021.